Nanobiotix S.A (NBTX) PT Raised to $46 at Leerink Jun 4, 2026 04:02AM
NANOBIOTIX closes global offering, raises $100 million May 26, 2026 04:51PM
Nanobiotix prices €85 million global offering of shares and warrants May 21, 2026 11:01AM
Nanobiotix S.A (NBTX) PT Raised to $30 at UBS May 1, 2026 06:24AM
Nanobiotix S.A (NBTX) PT Raised to $36 at Guggenheim Apr 2, 2026 06:42AM


Apr 1, 2026 11:17AM Nanobiotix S.A (NBTX) PT Raised to $37 at Leerink Partners
Mar 25, 2026 10:12AM NANOBIOTIX denies takeover speculation, cites media inaccuracies
Mar 25, 2026 07:26AM Nanobiotix stock jumps on takeover report involving J&J
Mar 12, 2026 09:31AM TD Cowen Highlights Nanobiotix S.A (NBTX) as 'Europe Best Ideas'
Feb 6, 2026 05:33AM TD Cowen Starts Nanobiotix S.A (NBTX) at Buy
Nov 25, 2025 05:19AM Nanobiotix S.A (NBTX) PT Raised to $26 at Leerink Partners
Oct 1, 2025 04:23AM Nanobiotix S.A (NBTX) PT Raised to $24 at Leerink Partners
Apr 4, 2025 07:03AM Nanobiotix S.A (NBTX) PT Lowered to $8 at Guggenheim
Mar 27, 2025 04:16PM Nanometrics (NANO) Announces First Data From Completed Dose Escalation Part of Phase 1 Study Evaluating NBTXR3 as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Aug 28, 2024 02:15AM Guggenheim Starts Nanobiotix S.A (NBTX) at Buy